Leading NTA to exceed client expectations: results focused, science minded and quality driven.
Michael Spiegel is an accomplished entrepreneurial leader with an executive career and NED experience spanning more than two decades and eight countries within start-ups, corporates, government, academia and not-for-profit sectors.
His unique experience ranges from establishing a world first automated antibody facility in Australia, a mobile app start-up, a German DNA engineering biotech company and multiple management positions in tech start-ups, finance and banking. He has a successful track record creating, productising, scaling and commercialising complex projects and innovative life sciences platforms to address changing market and community needs.
Prior to arriving in Australia in 2007, Michael spent 15 years in Europe, working at the European Molecular Biology Laboratory (EMBL) in Germany and Italy as well as a founding executive of Gene Bridges GmbH, a biotechnology company focused on genetic engineering using novel DNA technology where he successful led technology licensing deals with major international Pharma and Biotech companies. With over 20+ years international experience in the sector, he was on the Tecan AG Scientific Advisory Panel on Biotherapeutics from 2008-2010 and a Committee Member for the Victorian Biotechnology Action Plan 2011, and as Executive Secretary of the Leadership Advisory Board for the $153 million Australian Regenerative Medicine Institute (ARMI).
His expertise includes strategy, growth, leadership, cultural realignments and transformations, and stakeholder relations.
Michael is a sought-after speaker and commentator on topics relating to biotech, complexity, innovation, start-ups and scale-ups, leadership, culture, and courage. Michael looks forward to working with NTA’s partners and forging new collaborations into the future.
Michael holds an MSc, MBA and is a graduate of the Australian Institute of Company Directors (GAICD).
Committed partners in your clinical development journey.
Kathy has worked as a clinical researcher and in numerous senior roles within the pharmaceutical and biotechnology industry for almost 30 years. Kathy is an expert driver of clinical drug development, particularly in the design, management, and implementation of clinical trials.
Her experience encompasses all stages of drug and device development in many geographical regions and therapeutic areas: neurology, infectious diseases, dermatology, oncology, haematology and endocrinology. Kathy brings her extensive experience to the Role of Senior Business Development Manager where she looks forward to working closely with NTA’s client base.
Kathy has a BSc and a MEng. She has co-authored peer-reviewed publications and has presented at international conferences.
Rebecca has a unique and diverse career covering roles in clinical research, marketing and communications, and sales and key account management.
Rebecca’s marketing experience includes: generalist marketing and branding activities at CSL; heading up the marketing and communications program behind the iconic Australian Made, Australian Grown logo; and driving awareness of, and lead generation for Blue Ocean Strategy services via traditional and digital marketing efforts at Blue Ocean Strategy Australia.
At NTA, Rebecca combines her marketing and communications experience, together with her extensive clinical research knowledge to increase the reach and impact of NTA’s profile, position and visibility.
Enabling quality drug development at every step.
NTA is committed to ensuring the highest quality conduct of clinical studies. NTA strives to provide you with a service that fulfills the project scope, agreed costs, proposed timelines and achieves a high level of client satisfaction.
NTA is committed to:
— service excellence that meets, or exceeds your expectations
— compliance with applicable regualtions and GCP guidelines
— continuous customer focus and support
— continuous improvement of all our activities
Facilitating world-class clinical trials in neuroscience and beyond.
Our clinical operations team have extensive clinical research knowledge to drive superior results.